Correlation of chromosomal instability, telomere length and telomere maintenance in microsatellite stable rectal cancer: A molecular subclass of rectal cancer

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Boardman, Lisa A ^a   Johnson, Ruth A ^a   Viker, Kimberly B ^a   Hafner, Kari A ^a   Jenkins, Robert B ^a   Riegert Johnson, Douglas L ^a   Smyrk, Thomas C ^a   Litzelman, Kristin ^b   Seo, Songwon ^c   Gangnon, Ronald E ^b,c   Engelman, Corinne D ^b   Rider, David N ^a   Vanderboom, Russell J ^d   Thibodeau, Stephen N ^a   Petersen, Gloria M ^a   Skinner, Halcyon G ^b,c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d MAYO CLINIC CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASE SEQUENCE; CHROMOSOMAL INSTABILITY; COMPARATIVE GENOMIC HYBRIDIZATION; DNA PRIMERS; ENZYME ACTIVATION; GENES, P53; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; POINT MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; RECTAL NEOPLASMS; TELOMERASE; TELOMERE;

EID: 84894225185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080015     Document Type: Article

References (36)

1. Georgiades IB, Curtis LJ, Morris RM, Bird CC, Wyllie AH (1999) Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence of chromosomal or microsatellite instability. Oncogene 18: 7933-7940. PubMed: 10637503.
2. Tang R, Changchien CR, Wu M-C, Fan C-W, Liu K-W et al. (2004) Colorectal cancer without high microsatellite instability and chromosomal instability- an alternative genetic pathway to human colorectal cancer. Carcinogenesis 25(5): 841-846. PubMed: 14729584.
3. Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ et al. (2006) Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 131: 729-737. doi:10.1053/j.gastro.2006.06. 005. PubMed: 16952542.
4. Hawkins NJ, Tomlinson I, Meagher A, Ward RL (2001) Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer. Br J Cancer 84: 232-236. doi:10.1054/bjoc.2000.1554. PubMed: 11161382.
5. Campisi J, Kim SH, Lim CS, Rubio M (2001) Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol 36: 1619-1637. doi:10.1016/S0531-5565(01)00160-7. PubMed: 11672984.
6. Pampalona J, Soler D, Genescà A, Tusell L (2010) Whole chromosome loss is promoted by telomere dysfunction in primary cells. Genes Chromosomes Cancer 49: 368-378. PubMed: 20088004.
7. Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413. doi:10.1016/0092-8674(85)90170-9. PubMed: 3907856.
8. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248. PubMed: 7556065.
9. Boardman LA, Johnson RA, Petersen GM, Oberg AL, Kabat BF et al. (2007) Higher frequency of diploidy in young-onset microsatellite-stable colorectal cancer. Clin Cancer Res 13: 2323-2328. doi:10.1158/1078-0432.CCR-06-2739. PubMed: 17438090.
10. Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y et al. (2001) The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 69: 780-790. doi:10.1086/323658. PubMed: 11524701.
11. Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260: 816-819. doi:10.1126/science.8484122. PubMed: 8484122.
12. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM et al. (2002) Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 20: 1043-1048. doi:10.1200/JCO.20.4. 1043. PubMed: 11844828.
13. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR et al. (1998) National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257. PubMed: 9823339.
14. Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30(10): e47. doi:10.1093/nar/30.10.e47. PubMed: 12000852.
15. Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386: 623-627. doi:10.1038/386623a0. PubMed: 9121588.
16. Henson JD, Cao Y, Huschtscha Ll, Chang AC, Au AY et al. (2009) DNA C-circles are specific and quantifiable markers of alternative-lengthening-of- telomeres activity. Nat Biotechnol 27: 1181-1185. doi:10.1038/nbt.1587. PubMed: 19935656.
17. Fridlyand J, Dimitrov P (2010) aCGH: Classes and functions for Array Comparative Genomic Hybridization data. R package version 1.34.0.
18. Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ et al. (2013) A colorectal cancer classification system that associates cellular phenotype and responses to therapy.Nat Med 19(5): 619-625. doi:10.1038/nm.3175. PubMed: 23584089.
19. De Sousa E, Melo F, Wang X, Jansen M, Fessler E et al. (2013) Poorprognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med 19(5): 614-618. doi:10.1038/nm.3174. PubMed: 23584090.
20. Gisselsson D, Jonson T, Petersén Ä, Strömbeck B, Dal Cin P et al. (2001) Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc of the Natl Acad of Sciences of the USA 98: 12683-12688. doi:10.1073/pnas. 211357798. PubMed: 11675499.
21. Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M et al. (2003) Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361: 836-838. PubMed: 12642053.
22. Muntoni A, Reddel RR (2005) The first molecular details of ALT in human tumor cells. Hum Mol Genet 14: 191-196. doi:10.1093/hmg/ddi266. PubMed: 15548547.
23. Christodoulidou A, Raftopoulou C, Chiourea M (2013) The roles of telomerase in the generation of polyploidy during neoplastic cell growth. Neoplasia 5: 156-168. PubMed: 23441130.
24. Ibanez de Caceres I, Frolova N, Varkonyi RJ, Dulaimi E, Meropol D et al. (2004) Telomerase is frequently activated in tumors with microsatellite instability. Cancer Biol Ther 3: 289-292. doi:10.4161/cbt.3.3.695. PubMed: 14726659.
25. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK et al. (1990) Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868. doi:10.1038/346866a0. PubMed: 2392154.
26. Plentz RR, Wiemann SU, Flemming P,Meier PM, Kubicka S et al. (2003) Telomere shortening of epithelial cells characterizes the adenoma-carcinoma transition of human colorectal cancer. Gut 52: 1304-1307. doi:10.1136/gut.52.9. 1304. PubMed: 12912862.
27. Artandi SE, DePinho RA (2010) Telomeres and telomerase in cancer. Carcinogenesis 31: 9-18. doi:10.1093/carcin/bgp268. PubMed: 19887512.
28. Chang S-C, Lin J-K, Yang SH, Wang H-S, Li AF-Y et al. (2006) Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer 118: 1721-1727. PubMed: 16231316.
29. Stewart SA, Weinberg RA (2006) Telomeres: Cancer to human aging. Annu Rev Cell Dev Biol 22: 531-557. doi:10.1146/annurev.cellbio. 22.010305.104518. PubMed: 16824017.
30. Giaretti W, Venesio T, Sciutto A, Prevosto C, Geido E, et al. (2003) Near-diploid and near-triploid human sporadic colorectal adenocarcinomas differ for KRAS2 and TP53 mutational status. Genes Chromosomes Cancer 37: 207-213.
31. Lee AJ, Endesfelder D, Rowan AJ, Walther A, Birkbak NJ et al. (2011) Chromosomal instability confers intrinsic multidrug resistance. Cancer Res 71(5): 1858-1870. doi:10.1158/0008-5472.CAN-10-3604. PubMed: 21363922.
32. Yi B-Q, Zhao B, Wang Z-J (2011) Comparison of clinicopathological features and hRad21 expression between telomerase-dependent and telomerase-independent colorectal cancer. Hepatogastroenterology 58: 785-789. PubMed: 21830390.
33. Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA (2003) Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 17(1): 88-100. doi:10.1101/gad.1029903. PubMed: 12514102.
34. Joseph I, Tressler R, Bassett E, Harley C, Buseman CM et al. (2010) The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Cancer Res 70: 9494-9504. doi:10.1158/0008-5472. CAN-10-0233. PubMed: 21062983.
35. Tamakawa RA, Fleisig HB, Wong JM (2010) Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner. Cancer Res 70: 8684-8694. doi:10.1158/0008-5472.CAN-10- 2227. PubMed: 20837664.
36. Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407): 330-337. doi:10.1038/nature11252. PubMed: 22810696.